Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.216 EUR | -1.82% | -.--% | -82.78% |
04-29 | Mithra Pharmaceuticals to Postpone the Publication of Its Annual Report 2023 | CI |
04-22 | Mithra Pharmaceuticals Obtains Court Protection Measures | MT |
Sales 2023 | 40.16M 43.64M 3.44B | Sales 2024 * | 43.9M 47.71M 3.76B | Capitalization | 14.93M 16.22M 1.28B |
---|---|---|---|---|---|
Net income 2023 | -174M -189M -14.9B | Net income 2024 * | -55M -59.77M -4.71B | EV / Sales 2023 | 9.88 x |
Net Debt 2023 | 310M 337M 26.55B | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | 0.34 x |
P/E ratio 2023 * |
-0.16
x | P/E ratio 2024 * |
-
| Employees | 270 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 81.67% |
1 day | -1.82% | ||
1 month | -6.49% | ||
3 months | -63.58% | ||
6 months | -82.58% | ||
Current year | -82.78% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 22/02/17 | |
Stijn Vlaminck
CTO | Chief Tech/Sci/R&D Officer | - | 30/04/21 |
Graham Dixon
CTO | Chief Tech/Sci/R&D Officer | 63 | 31/03/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jacques Galloy
BRD | Director/Board Member | 53 | 28/05/23 |
Christian Homsy
CHM | Chairman | 65 | 28/05/23 |
Valérie Gordenne
BRD | Director/Board Member | 51 | 19/05/21 |
Date | Price | Change | Volume |
---|---|---|---|
17/05/24 | 0.216 | -.--% | 0 |
16/05/24 | 0.216 | -.--% | 0 |
15/05/24 | 0.216 | -.--% | 0 |
14/05/24 | 0.216 | -.--% | 0 |
13/05/24 | 0.216 | -.--% | 0 |
Real-time Euronext Bruxelles, April 26, 2024 at 04:35 pm
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-82.78% | 16.23M | |
-2.32% | 92.59B | |
+3.68% | 41.43B | |
-10.90% | 33.49B | |
-19.56% | 14.62B | |
-9.06% | 12.77B | |
-11.34% | 11.58B | |
-43.53% | 11.35B | |
+3.75% | 8.97B | |
-6.32% | 8.3B |
- Stock Market
- Equities
- MITRA Stock